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960Background: Risk factors and outcomes after iliofemoral complications after thoracic aortic endovascular re-
pair remain poorly characterized. This study was performed to characterize factors influencing perioperative
iliofemoral complications during thoracic aortic endovascular repair.
Methods: All patients undergoing transfemoral thoracic aortic endovascular repair since 2005 with adequate
preoperative aortoiliac 3-dimensional imaging (n ¼ 126) were identified. Assessment of imaging was blinded
with regard to occurrence of iliofemoral complications, defined as anything other than successful transfemoral
device delivery and primary closure of an arteriotomy.
Results: The complication rate was 12% (n ¼ 15). Univariate analysis identified that female gender, preoper-
ative ankle-brachial index, average and minimal iliac diameters, diameter difference between iliac artery and
sheath size, and iliac morphology score (calculated by combining iliac tortuosity, calcification, and vessel diam-
eter) were associated with iliofemoral complications (all P<.05). Multivariate analysis identified the (1) differ-
ence between average iliac diameter and sheath size (P ¼ .014), (2) iliac artery morphology score (P ¼ .033),
and (3) ankle-brachial index (P¼ .012) as independent predictors for iliofemoral complications. Early mortality
was higher in those with complications (13.3% vs 1.8%, P ¼ .069). Four-year freedom from limb loss, claudi-
cation, or revascularization was 97.9%. Iliofemoral complications reduced late survival primarily as a result of
increased mortality within the first year (P ¼ .047).
Conclusions: Thoracic aortic endovascular repair can be performed safely via a transfemoral approach. Alter-
native access in patients with high preoperative iliac artery morphology scores and device delivery size require-
ments over the native iliofemoral size may reduce iliofemoral complications. If early complications occur,
prompt repair results in low rates of ischemic limb complications at late follow-up. (J Thorac Cardiovasc
Surg 2014;147:960-5)Despite the successful introduction of thoracic endovascu-
lar aortic repair (TEVAR) as a minimally invasive therapeu-
tic option for the treatment of descending thoracic aortic
aneurysms, it is associated with access and device delivery
challenges. Passage of large-bore sheaths through diseased
iliofemoral access vessels often precludes safe transfemoral
TEVAR in up to 30% of patients.1 Although alternative
access routes, including ascending aortic, iliac, and subcla-
vian arteries, have been described, these options increase
the morbidity, duration of hospitalization, and postoperative
recovery of what is intended to be a minimally invasive
approach to aneurysm repair.2,3 Modifications to the
delivery catheters and sheaths (including tapered tips,
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The Journal of Thoracic and Cardiovascular Surgimproved trackability) have helped overcome some
aortoiliac anatomic limitations, but current series report
a 9% to 22% incidence of access complications, thus
contributing to perioperative morbidity in patients who
are frequently elderly and debilitated.4-6
No previous study has fully evaluated these challenges
with TEVAR, particularly with a rigorous 3-dimensional
(3-D) analysis of preoperative imaging studies. With the ad-
vent of other minimally invasive cardiovascular therapies,
including transcatheter aortic valve replacement, an exam-
ination of the incidence, risk factors for occurrence, and
early and late outcomes of iliofemoral complications
associated with large-bore diameter device delivery for
TEVAR is timely and warranted.MATERIALS AND METHODS
This single-center retrospective study was approved by the institutional
review board of the University of Michigan Medical School (HUM
00053164). The primary outcome in this study was the incidence of iliofe-
moral access complications. The definition of an iliofemoral access
complication was determined before beginning patient review and encom-
passed the following: (1) inability to successfully deliver the device into the
aorta via a transfemoral approach; (2) rupture, dissection, tear, or thrombo-
sis of the ipsilateral iliac artery or femoral artery, and (3) inability to
achieve primary closure of the femoral artery. Secondary outcomesery c March 2014
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ABI ¼ ankle-brachial index
IMS ¼ iliac morphology score
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TEVAR ¼ thoracic endovascular aortic repair
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from limb loss, claudication, or revascularization.
All patients who underwent TEVAR from March 2005 to August 2011
were reviewed for study eligibility (n ¼ 235). Before undergoing TEVAR,
all patients underwent computed tomographic arteriography with 3-D re-
constructions and modeling using M2S imaging software (M2S Inc,
West Lebanon, NH). Eighty patients were excluded from analysis on the
basis of available imaging for the following reasons: (1) emergency status
where time did not permit 3-D reconstruction, (2) 3-D models that did not
include the iliofemoral vessels, and (3) missing M2S hard-copy compact
discs with images no longer available for immediate review from the
M2S server. Twenty-nine patients were excluded from the analysis because
of planned delivery of the endograft via alternative access routes, including
the iliac conduit or aortofemoral limb (18), ascending aorta (10), and
carotid artery (1). The final study cohort consisted of 126 patients.
Preoperative demographics and postoperative outcomes were collected
retrospectively.
In 2002, a grading scale to objectively define the severity of anatomic
factors in abdominal aortic aneurysms was developed by the ad hoc Com-
mittee for the Standardized Reporting Practices in Vascular Surgery of the
Society for Vascular Surgery/American Association for Vascular Surgery.7
This scale designates a numeric value or score to the morphology of the
aortic neck, aortic aneurysm, and iliac artery. Specifically, the iliac mor-
phology score (IMS) includes extent of vessel calcification, vessel diameter
or presence of occlusive disease, and vessel angulation or tortuosity. All
available 3-D reconstructions were reviewed for the purpose of evaluating
iliac anatomy and calculating this IMS.
The 3-Dmodels were reviewed in a blinded fashion, such that the inves-
tigator did not know the operative and clinical outcome of the patient in
question. Because the IMS was initially conceived for the purpose of
TEVAR and included a component accounting for the landing zone of
the iliac limbs, we developed a modified version using 3 components to
evaluate the morphology of the iliac artery (Table 1). For the sake of sim-
plicity, the common and external iliac arteries were evaluated as a continu-
ous structure from the aortic bifurcation to the inguinal ligament, thus
allowing calculation of a single IMS. A numeric value was assigned on
the basis of varying degrees of calcification, artery diameter, and artery
tortuosity. Diameter was recorded as minimal luminal and representative
(average) diameter of the vessel. Tortuosity was calculated as the ratio be-
tween centerline luminal distance and straight line distance measured from
the aortic bifurcation to the distal external artery at the inguinal ligament
(Figure 1). The total score was calculated for the accessed side only,
with a maximal score of 9. To account for sheath oversizing, the outer
diameter of the sheath used to deliver the endograft in each patient was re-
corded in millimeters. In patients who received more than 1 endograft, the
largest sheath used was recorded. The difference between average iliac
diameter and sheath outer diameter was recorded as sheath oversizing.
All TEVARs were performed in hybrid operating rooms under general
anesthesia as previously described. Operative exposure of the femoral ar-
tery was performed via a 5-cm transverse infrainguinal incision. Percutane-
ous access was obtained in the contralateral femoral artery for placement of
a 5F sheath and a marked flush catheter.When intravascular ultrasound was
used, an 8F sheath was inserted. Ipsilateral femoral access was performedThe Journal of Thoracic and Cawith a single wall puncture needle and a single Lunderquist wire
(Cook Medical Inc, Bloomington, Ind) placed into the ascending aorta.
Routine serial dilation of the ipsilateral iliofemoral vessel with hydrophilic
dilators (Cook Medical Inc) up to a 24F size (or less if delivery sheath size
was smaller) was performed before introducing the endograft. TAG
(WL Gore & Associates, Flagstaff, Ariz), TX2 (Cook Medical Inc), and
Talent (Medtronic Inc, Minneapolis, Minn) endografts were used in this
study. After deployment and removal of all devices, the common femoral
artery was repaired with interrupted 5-0 polypropylene sutures, taking
care to tack down all intimal flaps. Distal arterial signals and Doppler in-
terrogation of the vessels were performed before closure of the wound.
Ankle-brachial indices (ABIs) were obtained routinely on the first or
second postoperative day. Completion imaging of the iliofemoral segment
was performed selectively for altered pulse or Doppler signal identified
after repairing the femoral artery.
Statistical Analysis
Statistical analysis was performed with SPSS (SPSS Inc, Chicago, Ill).
Dichotomous variables were evaluated using chi-square analysis or Fisher
exact test; continuous variables were evaluated using Student t test. Multi-
variatemodels (binary logistic regression)were constructed using a forward
conditional process to identify factors that were independently associated
with each of the outcomes of interest. Factors used in multivariate analysis
included those with a P value of .1 or less on univariate analysis. Survival
analysis was performed by Kaplan-Meier methods.RESULTS
Early Results
The mean age for the entire cohort was 68.7 years with
a slight predominance of male subjects (54.8%). The demo-
graphics are listed in Table 2. Femoral artery exposure was
made through a reoperative field in 12% of instances, and
a mean of 1.9 stent grafts were used per patient. Indications
for intervention included aneurysm (60%), aortic dissec-
tion (21%), blunt traumatic aortic injury (17%), and
penetrating ulcer (2%).
In 126 patients, there were 15 iliofemoral access compli-
cations, yielding a complication rate of 12%. In 8 patients,
there was a rupture or dissection of the iliac artery; in 6 pa-
tients, the femoral artery required patch angioplasty to
achieve closure. The endograft was unable to be delivered
into the aorta via the transfemoral route in 1 patient. The
presence of iliofemoral complications significantly in-
creased postoperative length of stay (no complication me-
dian length of stay 5 days vs complication length of stay
6.5 days, P ¼ .007).
By univariate analysis, those patients who sustained an
iliofemoral complication were more likely to be female,
to have smaller iliac arteries, and to have higher preopera-
tive ABIs (all P<.05, Table 3). These patients also demon-
strated more challenging anatomy as defined by a higher
IMS (no complication IMS 2.7 vs complication IMS 3.7,
P < .001). Device delivery sheaths were, on average,
more than 1 mm oversized in the complication cohort and
slightly undersized in those patients who did not sustain
a complication (Table 3). By multivariate analysis, indepen-
dent predictors of iliofemoral access complicationsrdiovascular Surgery c Volume 147, Number 3 961
TABLE 1. Iliac artery morphology score (7)
Attribute Absent ¼ 0 Mild ¼ 1 Moderate ¼ 2 Severe ¼ 3
Calcification None <25% vessel length 25%-50% vessel length >50% vessel length
Average diameter (d) d>10 mm d<8<10 mm d<7<8 mm d<7 mm
Iliac tortuosity index (t) t<1.25 t<1.25<1.5 t<1.5<1.6 t>1.6
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P ¼ .012), IMS (OR, 2.8; P ¼ .033), and sheath oversizing
(mean iliac artery diameter minus sheath outer diameter
OR, 0.38; P ¼ .014).
Early mortality, defined by in-hospital or 30-day death,
was higher in those patients who had an iliofemoral compli-
cation (13.3% vs 1.8%, P ¼ .069). The only intraoperative
death occurred in 1 patient who sustained an iliac artery rup-
ture. This 76-year-old woman undergoing elective TEVAR
for a 5.8-cm descending aneurysm sustained a distal iliac
artery rupture with resulting hypovolemic cardiac arrest
during passage of the delivery sheath. Despite emergency
iliac artery stent grafting with control, she was unable toFIGURE 1. Assessment of iliac artery tortuosity index. The Society for
Vascular Surgery iliac artery tortuosity index is determined by the ratio
of the iliac artery length along the centerline of blood flow and the simple
geometric straight line from the aortoiliac bifurcation to the femoral artery.
962 The Journal of Thoracic and Cardiovascular Surgbe resuscitated and died. Her IMS was 5, including a score
of 2 for calcification greater than 25% and 3 for a represen-
tative iliac diameter to sheath oversizing of 1.5 mm. The
only other early mortality in this study cohort was in
a 71-year-old woman with severe chronic obstructive pul-
monary disease undergoing TEVAR for an acute on chronic
type B dissection with a 6-cm aneurysm. She required intra-
operative left femoral patch angioplasty for reconstruction
of her iliofemoral segment. Her death was due to develop-
ment of permanent spinal cord ischemia with paralysis
and subsequent failure to wean from the ventilator. She
died on postoperative day 71 after comfort care measures











Age (y) 73.2  10.6 68.1  13.2 .15
Male sex 3 (20%) 66 (59.5%) .005
Diabetes 1 (6.7%) 17 (15.3%) .69
Coronary artery disease 4 (26.7%) 45 (40.5%) .4
Prior CABG 1 (6.7%) 18 (16.2%) .47
Prior PCI 2 (13.3%) 16 (14.4%) 1.0
Congestive heart failure 0 (0%) 10 (9.1%) .61
Carotid artery disease 2 (13.3%) 18 (16.2%) 1.0
Hypertension 13 (86.7%) 100 (90.1%) .66
Atrial fibrillation 3 (20%) 16 (14.4%) .77
COPD 4 (26.7%) 37 (33.3%) .77
History of tobacco abuse 12 (80%) 81 (73.0%) .76
PVOD 1 (6.7%) 16 (14.4%) .69
Preoperative ipsilateral ABI 1.1  0.1 1.0  0.2 .002
Prior AAA repair 5 (33.3%) 31 (27.9%) .76
Preoperative creatinine (mg/dL) 1.1  0.4 1.2  1.1 .89
Dialysis-dependent renal failure 0 (0%) 1 (0.9%) 1.0
Treated pathology
Aneurysm 10 (67%) 65 (58%) .59
Penetrating ulcer 1 (6.7%) 2 (1.8%) .78
Aortic dissection 4 (26.7%) 23 (20.7%) .73
Blunt thoracic aortic injury 0 (0%) 21 (18.9%) .32
Maximum aortic dimension (cm) 4.8  1.7 4.6  1.7 .7
Procedural details
Reoperative groin exposure 3 (20%) 12 (10.8%) .39
No. of endografts used per
procedure
2.2  0.8 1.9  1.0 .22
CABG, Coronary artery bypass grafting; PCI, percutaneous coronary intervention;
COPD, chronic obstructive lung disease; PVOD, peripheral vascular occlusive
disease; ABI, ankle-brachial index; AAA, abdominal aortic aneurysm.
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Patients (n) 15 111 N/A
Female gender n (%) 12 (80%) 45 (41%) .009
Age (y) 74.7  10.6 68.1  13.2 .16
Iliac tortuosity index 1.33  0.24 1.22  0.15 .15
Iliac calcium score 1.15  0.53 0.96  0.88 .48
Average iliac diameter (mm) 7.18  1.31 8.64  1.99 .015
Minimum iliac diameter (mm) 6.16  1.0 7.19  1.72 .041
IMS 3.77  0.72 2.75  1.39 <.001
Sheath oversizing (mm) 1.3  1.16 0.12  1.94 <.001
N/A, Not available; IMS, iliac morphology score.
FIGURE 3. Late survival according to iliofemoral complications. The
Kaplan–Meier survival analysis demonstrates that 4-year survival for the
entire cohort is 76.0% 5.3% (data not shown). When stratified by occur-
rence of perioperative iliofemoral complications, the 4-year survival is
greater in those without complications than in those with complications
(Wilcoxon P ¼ .047). As the curves show, the predominant force of mor-
tality is seen within the first year (no complication 1-year survival
Vandy et al Acquired Cardiovascular DiseaseLate Results
Kaplan–Meier analysis suggested that the 4-year free-
dom from limb loss, claudication, or revascularization
was 97.9%  2.1% (Figure 2). One identified late event
occurred in a man undergoing TEVAR for a 5.8-cm saccular
arch aneurysm. He sustained intraoperative external iliac
artery avulsion and underwent successful emergency iliac
artery stent graft repair. This limb thrombosed at 6 months
and manifested as lifestyle-limiting claudication with a de-
crease in ABI from 1.01 to 0.43. He underwent successful
iliofemoral bypass with a Dacron graft at 3 years with res-
olution of symptoms. The only other late event occurred inFIGURE 2. Freedom from late limb loss, claudication, or revasculariza-
tion. This Kaplan–Meier survival analysis suggests that the freedom
from limb loss, claudication, or revascularization at 4 years is
97.9%  2.1%.
90.0%  3.0% vs complication 1-year survival 73.3%  11.4%).
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tion of the ipsilateral side approximately 5 years after
TEVAR. He had developed intervening contralateral claudi-
cation requiring kissing balloon-expandable stents at the
aortoiliac bifurcation 6 months before this symptom. He
has responded well to maximummedical therapy, including
cilostazol (Pletal; Otsuka America Pharmaceutical, Inc,
Rockville, Md) therapy. There were no amputations in
either subgroup.
When Kaplan–Meier analysis was performed for the en-
tire cohort, the overall 4-year survival was 76.0%  5.3%.
Most important, when a comparative analysis was per-
formed, 4-year survival was significantly decreased in the
complication subgroup (Wilcoxon P ¼ .046). It is evident
from the survival curve (Figure 3) that mortality in the
complication subgroup predominantly occurs early after
the operative procedure.DISCUSSION
Endovascular approaches for a variety of thoracic aortic
pathologies have expanded since the initial approval of
the first thoracic endograft in 2005.2,8 These minimally
invasive treatment options have been successfully applied
even in patients traditionally considered high risk orrdiovascular Surgery c Volume 147, Number 3 963
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its less invasive appeal, TEVAR still has significant
limitations. A recent study by Jackson and colleagues9 sug-
gested significant anatomic constraints limiting the applica-
bility of TEVAR in all patients evaluated for treatment. In
their group of 126 patients evaluated for pivotal Food and
Drug Administration–sponsored clinical trials of the Gore
TAG and Medtronic Talent stent grafts, 33 patients were re-
jected on the basis of anatomic constraints. Although the
overwhelming number of patients were rejected from inclu-
sion into the trial on the basis of inadequate proximal or dis-
tal landing zones, 10 of the 33 (30.3%) were rejected
because of inadequate iliofemoral vessels. It should be
noted that this trial permitted use of iliac artery conduits
to aid in delivery, thus implying the rejection rate would
have been substantially higher if only transfemoral delivery
were considered.5
We have presented the largest series of patients undergo-
ing TEVAR in which the IMS was shown to be significantly
associated with an iliofemoral access complication. Al-
though underreported and most likely underused, the IMS
presents itself as a simple tool that should become part of
every patient’s preoperative planning to prevent delivery
complications. These data suggest that in a patient with
a score greater than 3, careful consideration should be given
to alternative access. Certainly, it is relevant to consider
how the total IMS was derived. A diminutive vessel with
no angulation or calcification that scores a 3 is a different
anatomic challenge than a large soft vessel that also scores
a 3 because of severe tortuosity. Furthermore, the IMS score
should be used in conjunction with other clinical factors,
such as patient gender and size of intended device. This
study demonstrated female gender to be a risk factor for
complication, yet this is most likely attributable to small
vessel diameter, because it is well known that women
have smaller iliofemoral vessels than men. In addition,
sheath oversizing was independently associated with a com-
plication. As shown in Table 2, delivery of a sheath over-
sized by just 1 mm was associated with an iliofemoral
complication. On the contrary, in the cohort that did not sus-
tain a complication, the sheaths used were, on average,
slightly smaller than the iliac artery.
This study also demonstrated that higher preoperative
ABIs were independently associated with iliofemoral com-
plications. This was an unexpected finding. On review of
our database, we note that many patients in the complica-
tion cohort had ABIs exceeding 1.1. It is unclear whether
this represents widespread arterial calcification. In this
sense, ABIs elevated above normal rangemay be a surrogate
marker for occlusive disease. Drawing conclusions from the
ABI alone without knowledge of pulse volume recordings
or cross-sectional lower-extremity imaging is limited.
The iliofemoral access complication rate (12%) reported
in this study was consistent with previous reports, even964 The Journal of Thoracic and Cardiovascular Surgthough 29 patients had been culled from the original cohort
because of planned alternate access.5,6 Although some of
these were planned in conjunction with additional
procedures, such as TEVAR after arch debranching via
median sternotomy, some of the exclusions resulted from
preoperative judgment of inadequate iliofemoral access.
In retrospect, an alternative delivery path such as
a retroperitoneal iliac artery conduit would have been
appropriate in even more of these patients. However, the
decision to use a conduit to facilitate endograft delivery
should be carefully considered in those patients with
hostile iliac anatomy. The iliac conduit via retroperitoneal
exposure has traditionally been the most common type of
conduit used. However, as suggested by Lee and
colleagues,10 this procedure is associated with increased
morbidity. In their series of 164 patients undergoing an ab-
dominal aortic endovascular repair, those patients who re-
quired an iliac conduit had a 2.6-fold increase in blood
loss, 82% longer procedure time, 1.5 days additional hospi-
tal stay, and a 1.8-fold higher rate of perioperative compli-
cations. Similar results focusing just on patients undergoing
TEVAR have been reported by Etezadi and colleagues.11
There was no significant difference in mortality in either
study, which led the authors to conclude that although retro-
peritoneal procedures are significantly associated with lon-
ger hospital stay and more complications, such surgical
procedures can significantly expand the number of patients
who can undergo endovascular repair.
Given the operative morbidity associated with retroperi-
toneal conduits, other groups have described the less-
invasive internal endoconduit.3,12 In this procedure,
a stent graft is deployed in the narrowed iliac segment,
and an intentional rupture of the covered iliac segment is
performed to allow safe delivery of a large-bore sheath.
This technique must be used with caution in patients with
innately small vessels. Furthermore, it may be necessary
to exclude the hypogastric artery, which after TEVAR can
contribute to an increased risk of spinal cord ischemia.13
The use of 3-Dmodeling is imperative not only to size the
endograft but also to accurately derive the IMS. We rou-
tinely obtain 3-D vessel analysis on all patients undergoing
elective or urgent TEVAR. Our current experience suggests
that even in the setting of isolated thoracic aortic aneurysm
disease, imaging of the aortoiliac and iliofemoral anatomy
should be required before endovascular aortic repair. Cen-
terline creation enables accurate measurements of seal
zones, tortuosity, and C-arm correction angles.14
Study Limitations
The main limitations of this study include its retrospec-
tive nature and small sample size. Another limitation in-
cludes the lack of 3-D imaging availability in all the
patients treated during this study period. However, it repre-
sents the only study to date to our knowledge that assessesery c March 2014
Vandy et al Acquired Cardiovascular Diseasethe impact of iliofemoral complications after TEVAR on
early and late outcomes.
CONCLUSIONS
Iliofemoral complication rates remain low after TEVAR.
Although prompt recognition and repair of these complica-
tions allow a low rate of late limb ischemia, their occurrence
portend a decrease in midterm survival. With the advent of
newer endovascular treatments such as transcatheter aortic
valve replacement, 3-D imaging including calculation of
an IMS constitutes an important aspect of the preoperative
evaluation to reduce iliofemoral access complications and
allow a successful minimally invasive treatment.
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